SUBSCRIBE
SUBSCRIBE

Preclinical

Drug Development
Combination of Viagra and Anti-Cancer Drug Shrinks Tumors in Vivo, Researchers Discover, Virginia Commonwealth University Study
September 28, 2010
 · 
1 min read
Drug Development
Molecular ‘Playbook’ for Halting Heart Failure Risk Factor Uncovered, University of Rochester Medical Center Study
September 27, 2010
 · 
1 min read
Drug Development
Researchers Create First Molecule that Blocks Key Component of Cancer Genes’ On-off Switch, Oxford University Study
September 27, 2010
 · 
1 min read
Drug Development
Light Workout: Optogenetics to Effectively Stimulate Muscle Movement in Mice, Stanford University Study
September 27, 2010
 · 
1 min read
Drug Development
Genetic Discovery Could Lead to Brain Treatments, Medical Research Council Study
September 27, 2010
 · 
1 min read
Drug Development
Scientists from Basque Center for Cooperative Research in Biosciences and OWL Genomics Develop Blood Test for Fatty Liver Disease
September 23, 2010
 · 
1 min read
Drug Development
Toward the First Nose Drops to Treat Brain Cancer, Study Published in ACS’ Molecular Pharmaceutics
September 23, 2010
 · 
1 min read
Drug Development
Vitamin D Protects Against Obesity-Induced Endometrial Cancer, National Cancer Institute and Collaborators Study Suggests
September 22, 2010
 · 
1 min read
Drug Development
Biochemical Link Between Biological Clock And Diabetes Discovered, University of California, San Diego (UCSD) Study
September 20, 2010
 · 
1 min read
Drug Development
Gene Limits Learning and Memory in Mice, Emory University Study
September 20, 2010
 · 
1 min read
Load More
PRESS RELEASES
Drug Development
Sonoma Biotherapeutics to Present Preclinical Data from Novel Treg Cell Therapy for Rheumatoid Arthritis at American College of Rheumatology Convergence 2022
November 10, 2022
 · 
2 min read
Drug Development
KaliVir Immunotherapeutics Announces Pre-Clinical Data for Oncolytic Therapy VET3-TGI at the Society for Immunology of Cancer (SITC) 37th Annual Meeting
November 10, 2022
 · 
3 min read
Drug Development
SOTIO Presents Preclinical Data from BOXR CAR-T Program and Trial Design of Phase 2 AURELIO-04 Study at SITC Annual Meeting
November 10, 2022
 · 
5 min read
Drug Development
CytomX Therapeutics to Present Preclinical Data for Conditionally Activated Interferon Alpha-2b (CX-801) at the SITC 2022 Annual Meeting
November 7, 2022
 · 
6 min read
Drug Development
Navidea Biopharmaceuticals Announces Details of Presentation at Upcoming Society for Immunotherapy of Cancer Annual Meeting
November 7, 2022
 · 
6 min read
Drug Development
Werewolf Therapeutics to Present Preclinical Data at Society for Immunotherapy of Cancer Annual Meeting and Participate in Upcoming Investor Conferences
November 7, 2022
 · 
2 min read
Drug Development
Keros Therapeutics Presents Preclinical Data from its KER-012 Program at the American Heart Association 2022 Scientific Sessions
November 7, 2022
 · 
5 min read
Drug Development
Adicet Bio Showcases Preclinical Data for Four New Pipeline Programs at The Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting
November 7, 2022
 · 
6 min read
Drug Development
OliX Pharmaceuticals Announces Positive Preclinical Data in NASH Non-human Primate Models
November 7, 2022
 · 
2 min read
Drug Development
Shattuck Labs Presents Updated Preclinical Data on Gamma Delta T Cell Engager (GADLEN) Platform Candidates at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 7, 2022
 · 
3 min read
Drug Development
TCR² Therapeutics Presents Preclinical Data on Functional Activity of Gavo-cel at the Society for Immunotherapy of Cancer
November 7, 2022
 · 
5 min read
Drug Development
Bolt Biotherapeutics to Present Preclinical Data on BDC-3042, Dectin-2 Targeting Agonistic Antibody, at the SITC Annual Meeting
November 7, 2022
 · 
3 min read
Drug Development
Maze Therapeutics Presents Preclinical Data Highlighting Potential of APOL1 Inhibitor Program as a Treatment for Chronic Kidney Disease
November 4, 2022
 · 
5 min read
Drug Development
Asher Bio Presents New Data Demonstrating Preclinical Proof-of-Concept for AB359, a Highly Selective CD8-Targeted IL-2 Therapy, for Chronic Hepatitis B (HBV) at AASLD 2022
November 4, 2022
 · 
4 min read
Drug Development
Cellectis to Showcase Clinical Data from AMELI-01 and Preclinical Data from UCARTCS1 at ASH 2022
November 3, 2022
 · 
7 min read
Drug Development
Sionna Therapeutics Presents Preclinical Data Demonstrating Restoration of ΔF508-CFTR by Stabilizing NBD1 with SION-638 in Cystic Fibrosis
November 3, 2022
 · 
4 min read
Drug Development
Artiva Announces Abstract Accepted for Presentation at the 64th American Society of Hematology Annual Meeting & Exposition
November 3, 2022
 · 
4 min read
Drug Development
Asher Bio to Present New Preclinical Data for Selective Support of CAR-T Cell Therapies by Cis-Targeted IL-2 and IL-21 Cytokines at ASH 2022
November 3, 2022
 · 
2 min read
Drug Development
Orum Therapeutics Announces Presentation at ASH 2022 Annual Meeting
November 3, 2022
 · 
4 min read
Drug Development
Fate Therapeutics to Present Clinical and Preclinical Data for iPSC Product Platform at the 2022 ASH Annual Meeting
November 3, 2022
 · 
11 min read
Load More